Skip to main content
logo
Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.370
-0.060 (-4.20%)
At close: Jul 16, 2026, 4:00 PM EDT
1.360
-0.010 (-0.73%)
Pre-market: Jul 17, 2026, 8:10 AM EDT

Ocugen Revenue

Ocugen had revenue of $1.53M in the quarter ending March 31, 2026, with 3.51% growth. This brings the company's revenue in the last twelve months to $4.47M, down -1.26% year-over-year. In the year 2025, Ocugen had annual revenue of $4.41M with 8.83% growth.

Revenue (ttm)
$4.47M
Revenue Growth
-1.26%
P/S Ratio
103.87
Revenue / Employee
$38,491
Employees
116
Market Cap
463.77M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.41M358.00K8.83%
Dec 31, 20244.06M-1.98M-32.82%
Dec 31, 20236.04M3.55M142.60%
Dec 31, 20222.49M--
Dec 31, 2021---
Dec 31, 202043.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20138.00K-18.00K-69.23%
Dec 31, 201226.00K-97.00K-78.86%
Dec 31, 2011123.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE180.25M
Verastem49.59M
Editas Medicine38.69M
Ovid Therapeutics7.12M
ProKidney889.00K
Silence Therapeutics839.00K
Artiva Biotherapeutics251.00K
Revenue Rankings

OCGN News

More News